Christie Mitchell Ballantyne

Christie Mitchell Ballantyne, M.D., is a Professor at Baylor College of Medicine, where he holds multiple leadership roles including Section Chief of Cardiology and Cardiovascular Research, Director of the Maria and Alando J. Ballantyne, M.D. Atherosclerosis Clinical Research Laboratory, and Director of the Center for Cardiometabolic Disease Prevention. He also co-leads the Lipid Metabolism and Atherosclerosis Clinic.

Education

• M.D., Baylor College of Medicine (1982)
• B.A., University of Texas at Austin (1977)
• Fellowships: Howard Hughes Medical Institute, Baylor College of Medicine (1989); Cardiology, University of Texas Southwestern (1985-1987)

Research Interests
Dr. Ballantyne's work focuses on clinical and translational research in hereditary lipid disorders, aiming to prevent cardiometabolic diseases through:

• Genetic epidemiology of lipid-related diseases
• Pharmacological interventions (e.g., statins, bempedoic acid)
• Multi-omics approaches (genomics, proteomics, metabolomics)
• Atherosclerosis progression and risk stratification
• Personalized preventive strategies

Publication Trends emphasize lipid-lowering therapies, cardiovascular biomarkers (e.g., high-sensitivity troponin, hs-cTnI), and clinical trial outcomes (e.g., REDUCE-IT, CLEAR Harmony) for cardiometabolic risk reduction.

Scientific Awards

• Castle Connolly Top Doctor (2024)

Additional Roles include leading the Atherosclerosis Clinical Research Laboratory and developing precision medicine strategies integrating genetic profiles with clinical phenotyping.